These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12477243)

  • 1. Role of the C-domain in the biological activities of Clostridium perfringens alpha-toxin.
    Nagahama M; Mukai M; Morimitsu S; Ochi S; Sakurai J
    Microbiol Immunol; 2002; 46(10):647-55. PubMed ID: 12477243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens.
    Nagahama M; Oda M; Kobayashi K; Ochi S; Takagishi T; Shibutani M; Sakurai J
    Microbiol Immunol; 2013 May; 57(5):340-5. PubMed ID: 23668605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific mutagenesis of Clostridium perfringens alpha-toxin: replacement of Asp-56, Asp-130, or Glu-152 causes loss of enzymatic and hemolytic activities.
    Nagahama M; Nakayama T; Michiue K; Sakurai J
    Infect Immun; 1997 Aug; 65(8):3489-92. PubMed ID: 9234819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-directed mutagenesis of histidine residues in Clostridium perfringens alpha-toxin.
    Nagahama M; Okagawa Y; Nakayama T; Nishioka E; Sakurai J
    J Bacteriol; 1995 Mar; 177(5):1179-85. PubMed ID: 7868589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase C produced by Clostridium botulinum types C and D: comparison of gene, enzymatic, and biological activities with those of Clostridium perfringens alpha-toxin.
    Fatmawati NN; Sakaguchi Y; Suzuki T; Oda M; Shimizu K; Yamamoto Y; Sakurai J; Matsushita O; Oguma K
    Acta Med Okayama; 2013; 67(1):9-18. PubMed ID: 23439504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of residues in the carboxy-terminal domain of Clostridium perfringens alpha-toxin (phospholipase C) which are required for its biological activities.
    Walker N; Holley J; Naylor CE; Flores-Díaz M; Alape-Girón A; Carter G; Carr FJ; Thelestam M; Keyte M; Moss DS; Basak AK; Miller J; Titball RW
    Arch Biochem Biophys; 2000 Dec; 384(1):24-30. PubMed ID: 11147832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of membrane damage by Clostridium perfringens alpha-toxin.
    Nagahama M; Michiue K; Mukai M; Ochi S; Sakurai J
    Microbiol Immunol; 1998; 42(8):533-8. PubMed ID: 9776394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tryptophan-1 in hemolytic and phospholipase C activities of Clostridium perfringens alpha-toxin.
    Nagahama M; Mukai M; Ochi S; Sakurai J
    Microbiol Immunol; 2000; 44(7):585-9. PubMed ID: 10981831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of tyrosine-57 and -65 in membrane-damaging and sphingomyelinase activities of Clostridium perfringens alpha-toxin.
    Nagahama M; Otsuka A; Sakurai J
    Biochim Biophys Acta; 2006 Jan; 1762(1):110-4. PubMed ID: 16278077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of site-directed mutagenesis to probe structure-function relationships of alpha-toxin from Clostridium perfringens.
    Guillouard I; Garnier T; Cole ST
    Infect Immun; 1996 Jul; 64(7):2440-4. PubMed ID: 8698464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico, in vitro and in vivo analysis of binding affinity between N and C-domains of Clostridium perfringens alpha toxin.
    Uppalapati SR; Kingston JJ; Qureshi IA; Murali HS; Batra HV
    PLoS One; 2013; 8(12):e82024. PubMed ID: 24349173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of recombinant baculovirus expressing atoxic C-terminal CPA toxin of Clostridium perfringens and production of specific antibodies.
    Forti K; Cagiola M; Pellegrini M; Anzalone L; Di Paolo A; Corneli S; Severi G; De Giuseppe A
    BMC Biotechnol; 2020 Jan; 20(1):7. PubMed ID: 31992276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic and sphingomyelinase activities of Clostridium perfringens alpha-toxin are dependent on a domain homologous to that of an enzyme from the human arachidonic acid pathway.
    Titball RW; Leslie DL; Harvey S; Kelly D
    Infect Immun; 1991 May; 59(5):1872-4. PubMed ID: 1902199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first strain of Clostridium perfringens isolated from an avian source has an alpha-toxin with divergent structural and kinetic properties.
    Justin N; Walker N; Bullifent HL; Songer G; Bueschel DM; Jost H; Naylor C; Miller J; Moss DS; Titball RW; Basak AK
    Biochemistry; 2002 May; 41(20):6253-62. PubMed ID: 12009886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a membrane-spanning domain of the thiol-activated pore-forming toxin Clostridium perfringens perfringolysin O: an alpha-helical to beta-sheet transition identified by fluorescence spectroscopy.
    Shepard LA; Heuck AP; Hamman BD; Rossjohn J; Parker MW; Ryan KR; Johnson AE; Tweten RK
    Biochemistry; 1998 Oct; 37(41):14563-74. PubMed ID: 9772185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of Alpha-Toxin-Deficient Clostridium perfringens Type F from Sewage Influents and Effluents.
    Yanagimoto K; Haramoto E
    Microbiol Spectr; 2021 Sep; 9(1):e0021421. PubMed ID: 34259541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and purification of functional Clostridium perfringens alpha and epsilon toxins in Escherichia coli.
    Zhao Y; Kang L; Gao S; Zhou Y; Su L; Xin W; Su Y; Wang J
    Protein Expr Purif; 2011 Jun; 77(2):207-13. PubMed ID: 21300155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The carboxy-terminal C2-like domain of the alpha-toxin from Clostridium perfringens mediates calcium-dependent membrane recognition.
    Guillouard I; Alzari PM; Saliou B; Cole ST
    Mol Microbiol; 1997 Dec; 26(5):867-76. PubMed ID: 9426125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of rabbits with recombinant Clostridium perfringens alpha toxins CPA-C and CTB-CPA-C in a bicistronic design expression system confers strong protection against challenge.
    Peng X; Peng G; Li X; Feng L; Dong L; Jiang Y
    Protein Expr Purif; 2020 Mar; 167():105550. PubMed ID: 31811913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Threonine-74 is a key site for the activity of Clostridium perfringens alpha-toxin.
    Nagahama M; Sakurai J
    Microbiol Immunol; 1996; 40(3):189-93. PubMed ID: 8934672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.